Aslani, Mineva .
HRN: 14-85-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2026
CIPROFLOXACIN 500MG (TAB)
03/31/2026
04/06/2026
PO
500 Mg
Bid
Infectious Diarrhea, UTI
Checking Initial Appropriateness
04/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2026
04/07/2026
IV
500 Mg
Q8h
Amoebiasis
Checking Initial Appropriateness